KLBF - Continuous inovations on biological products

KLBF - Continuous inovations on biological products Kalbe Farma (KLBF) through its subsidiary, Genexine Biologics (KGbio), collaborates with Shanghai Henlius Biotech for immuno-oncology products. KGbio focuses on bringing biological medical innovations to the export market. KGbio's business model includes licensing new biologics and certain biosimilars in oncology and specialized therapeutic areas. KLBF targets KGbio to acquire 12-15 products in the next 3-5 years. KGbio will also continue to do other collaborations, in order to produce new products together. (Source : Bisnis Indonesia)